View in EDS

Immune checkpoint inhibitor combinations-current and emerging strategies.

Saved in:
Bibliographic Details
Title: Immune checkpoint inhibitor combinations-current and emerging strategies.
Authors: Walsh RJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore., Sundar R; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; Singapore Gastric Cancer Consortium, Singapore, Singapore., Lim JSJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore. csilsjj@nus.edu.sg.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. csilsjj@nus.edu.sg.; Cancer Science Institute, Singapore, National University of Singapore, Singapore, Singapore. csilsjj@nus.edu.sg.
Source: British journal of cancer [Br J Cancer] 2023 Apr; Vol. 128 (8), pp. 1415-1417. Date of Electronic Publication: 2023 Feb 06.
Publication Type: Editorial
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36747017
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immune checkpoint inhibitor combinations-current and emerging strategies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Walsh+RJ%22">Walsh RJ</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Sundar+R%22">Sundar R</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.; Singapore Gastric Cancer Consortium, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+JSJ%22">Lim JSJ</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore. csilsjj@nus.edu.sg.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. csilsjj@nus.edu.sg.; Cancer Science Institute, Singapore, National University of Singapore, Singapore, Singapore. csilsjj@nus.edu.sg.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2023 Apr; Vol. 128 (8), pp. 1415-1417. <i>Date of Electronic Publication: </i>2023 Feb 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36747017
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-023-02181-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1415
    Titles:
      – TitleFull: Immune checkpoint inhibitor combinations-current and emerging strategies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Walsh RJ
      – PersonEntity:
          Name:
            NameFull: Sundar R
      – PersonEntity:
          Name:
            NameFull: Lim JSJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2023 Apr
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 128
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1